Enjoy complimentary customisation on priority with our Enterprise License!
This report covers the present scenario and the growth prospects of the global animal antimicrobials and antibiotics market for the period 2015-2019. To calculate the market size, the report considers revenue generated through sales of various antibiotics and antimicrobials intended for use in animals.
Technavio's report, Global Animal Antimicrobials and Antibiotics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and EMEA and APAC; it also covers the global animal antimicrobials and antibiotics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Veterinary Drug Approval Process
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Chemical Class
08.1 Tetracyclines
08.2 Penicillins
08.3 Sulfonamides
08.4 Macrolides
08.5 Aminoglycosides
08.6 Cephalosporins
08.7 Others
09. Market Segmentation by Type of Animal
09.1 Aquatic Animals
09.2 Farm Animals
09.3 Companion Animals
10. Geographical Segmentation
10.1 Global Animal Antimicrobials and Antibiotics Market by Geographical Segmentation 2014-2019
10.2 Animal Antimicrobials and Antibiotics Market in Americas
10.2.1 Market Size and Forecast
10.3 Animal Antimicrobials and Antibiotics Market in EMEA
10.3.1 Market Size and Forecast
10.3.2 Animal Antimicrobials and Antibiotics Market in APAC Market Size and Forecast
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2014
18.2.1 Zoetis
18.2.2 Merck Animal Health
18.2.3 Merial
18.2.4 Elanco
18.2.5 Bayer
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Bayer
19.1.1 Key facts
19.1.2 Business Overview
19.1.3 Business segmentation by revenue 2014
19.1.4 Business segmentation by revenue 2013 and 2014
19.1.5 Geographical segmentation by revenue 2014
19.1.6 Business strategy
19.1.7 Recent developments
19.1.8 SWOT analysis
19.2 Elanco Animal Health
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Strategy
19.2.4 Recent Developments
19.2.5 SWOT Analysis
19.3 Merck Animal Health
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Strategy
19.3.4 Recent Developments
19.3.5 SWOT Analysis
19.4 Merial
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Strategy
19.4.4 Recent Developments
19.4.5 SWOT Analysis
19.5 Zoetis
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Business Segmentation by Revenue 2013
19.5.4 Business Segmentation by Revenue 2012 and 2013
19.5.5 Geographical Segmentation by Revenue 2013
19.5.6 Business Strategy
19.5.7 Recent Developments
19.5.8 SWOT Analysis
20. Other Reports in this Series
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.